Joint meeting with HIV Pathogenesis and Cure
HIV Vaccines
June 1-4, 2021 | 9:00AM EDT | 1:00PM UTC | 3:00PM CEST*
*Program is in development and subject to change
Joint Meetings
Your registration provides you with access to both the “HIV Vaccines” and “HIV Pathogenesis and Cure” eSymposia events. Use the link below to explore the joint meeting features, including live plenary sessions, On Demand talks, posters, forums, job postings, 1:1 Connect appointments and more. This joint meeting access is designed to facilitate cross-disciplinary insights and collaborations to drive both fields in exciting new directions!
Preferred
(EDT)
Happening
Any Time
Dates
Tracks
Speakers
Rooms
Showing results 1 - 10 of 11
Tuesday, June 1, 2021
[Joint Session] Welcoming Remarks and Keynote Session
9:00 AM - 10:10 AM EDT
Tuesday, June 1, 2021Room: V300 - Chad Littman Co-Chairs
Persephone Borrow, PhD
University of Oxford
Carine Van Lint, PhD
University of Brussels
[Joint Session] Welcoming Remarks and Keynote Session
Accelerating HIV Vaccine Development to Prevent HIV Infection
9:00 AM - 9:35 AM EDT
Tuesday, June 1, 2021Room: V300 - Chad Littman Speaker
M. McElrath, MD, PhD
Fred Hutchinson Cancer Research Center
[Joint Session] Welcoming Remarks and Keynote Session
I Am Nothing Without You: The Rationale for T Cell Plus B Cell Vaccines for HIV
9:35 AM - 10:10 AM EDT
Tuesday, June 1, 2021Room: V300 - Chad Littman Speaker
Bruce Walker, MD
Ragon Institute of MGH, MIT and Harvard
[Joint Session] Welcoming Remarks and Keynote Session
[Joint Session] Breakthrough Technologies
10:10 AM - 11:45 AM EDT
Tuesday, June 1, 2021Room: V200 - Ian Loudon Co-Chairs
Robert Siliciano, MD, PhD
Johns Hopkins University School of Medicine
Michael Betts, PhD
University of Pennsylvania
[Joint Session] Breakthrough Technologies
Tonsil Organoid Culture System
10:10 AM - 10:35 AM EDT
Tuesday, June 1, 2021Room: V200 - Ian Loudon Speaker
Mark Davis, PhD
Stanford University School of Medicine
[Joint Session] Breakthrough Technologies
What Have We Learned from HIV-Barcoding Technologies?
10:35 AM - 11:00 AM EDT
Tuesday, June 1, 2021Room: V200 - Ian Loudon Speaker
Guillaume Filion, PhD
University of Toronto Scarborough
[Joint Session] Breakthrough Technologies
Short Talk: Spatial Profiling of HIV-1 Transmission in Lymphoid Tissues from Humanized Mice and Human Patients with Single-Cell to Single-Virus Resolution
11:00 AM - 11:15 AM EDT
Tuesday, June 1, 2021Room: V200 - Ian Loudon Speaker
Collin Kieffer, PhD
University of Illinois at Urbana-Champaign
[Joint Session] Breakthrough Technologies
Short Talk: Visualization of HIV Integration and Latency by CasFISH: In situ Imaging System for Localization of the Provirus and its Transcriptional Regulators in Infected Cells
11:15 AM - 11:30 AM EDT
Tuesday, June 1, 2021Room: V200 - Ian Loudon Speaker
Fredrick Kizito, PhD
Case Western Reserve University
[Joint Session] Breakthrough Technologies
Short Talk: Evolutionary Dynamics of HIV-1 Reservoir Cells Revealed by a Novel Multi-Dimensional Single-Cell Assay
11:30 AM - 11:45 AM EDT
Tuesday, June 1, 2021Room: V200 - Ian Loudon Speaker
Matthew Osborn, MS
Ragon Institute of MGH, MIT and Harvard
[Joint Session] Breakthrough Technologies
Insights from Preclinical and Clinical Trials
12:05 PM - 2:00 PM EDT
Tuesday, June 1, 2021Room: V300 - Chad Littman Co-Chairs
M. McElrath, MD, PhD
Fred Hutchinson Cancer Research Center
Barton Haynes, MD
Director, Duke Human Vaccine Institute
Insights from Preclinical and Clinical Trials
AMP Trial Results
12:05 PM - 12:30 PM EDT
Tuesday, June 1, 2021Room: V300 - Chad Littman Speaker
Lawrence Corey, MD
Fred Hutchinson Cancer Research Center
Insights from Preclinical and Clinical Trials
Optimizing Adjuvants for Clinical Vaccine Development
12:30 PM - 12:55 PM EDT
Tuesday, June 1, 2021Room: V300 - Chad Littman Speaker
Sandhya Vasan, MD
US Military HIV Research Program
Insights from Preclinical and Clinical Trials
Human Clinical Test of Germline Targeting: Preliminary Report on B-Cell Responses in the IAVI G001 Trial of eOD-GT8 60mer
12:55 PM - 1:20 PM EDT
Tuesday, June 1, 2021Room: V300 - Chad Littman Speaker
William Schief, PhD
International AIDS Vaccine Initiative and The Scripps Research Institute
Insights from Preclinical and Clinical Trials
Accelerated Experimental Medicine Trials for Iterative Vaccine Design
1:20 PM - 1:45 PM EDT
Tuesday, June 1, 2021Room: V300 - Chad Littman Speaker
Robin Shattock, PhD
Imperial College London
Insights from Preclinical and Clinical Trials
Short Talk: Efficacy of a Novel Epithelial Stem Cell-based AIDS Vaccine to Induce Mucosal Immune Responses and Control SIV Transmission in Macaques
1:45 PM - 2:00 PM EDT
Tuesday, June 1, 2021Room: V300 - Chad Littman Speaker
Marie-Claire Gauduin, PhD
Texas Biomedical Research Institute
Insights from Preclinical and Clinical Trials
[Joint Session] Career Roundtable
3:00 PM - 4:00 PM EDT
Tuesday, June 1, 2021Panelists
Devi SenGupta, MD
Gilead Sciences, Inc.
Kevin Saunders, PhD
Duke University
Bruce Walker, MD
Ragon Institute of MGH, MIT and Harvard
Keystone Symposia Roundtables
Wednesday, June 2, 2021
Immunogen Design for Broadly Neutralizing Antibody Induction
9:00 AM - 11:25 AM EDT
Wednesday, June 2, 2021Room: V300 - Chad Littman Co-Chairs
Wilton Williams, PhD
Duke University
Christine Daniels, PhD
Duke University
Immunogen Design for Broadly Neutralizing Antibody Induction
Induction of Neutralizing HIV Antibodies by Native-Like SOSIP Trimers
9:00 AM - 9:25 AM EDT
Wednesday, June 2, 2021Room: V300 - Chad Littman Speaker
Rogier Sanders, PhD
University of Amsterdam and Weill Cornell Medical College
Immunogen Design for Broadly Neutralizing Antibody Induction
Cryo-EM Polyclonal Epitope Mapping as a Tool to Accelerate Immunogen Design
9:25 AM - 9:50 AM EDT
Wednesday, June 2, 2021Room: V300 - Chad Littman Speaker
Gabriel Ozorowski, PhD
The Scripps Research Institute
Immunogen Design for Broadly Neutralizing Antibody Induction
Structural Details of Antibody Interactions with the HIV-1 Glycan Shield and Implications for Vaccine Design
9:50 AM - 10:15 AM EDT
Wednesday, June 2, 2021Room: V300 - Chad Littman Speaker
Priyamvada Acharya, PhD
Duke University
Immunogen Design for Broadly Neutralizing Antibody Induction
Vaccine Elicitation of CD4 Binding Site Neutralizing Antibodies in Macaques
10:15 AM - 10:40 AM EDT
Wednesday, June 2, 2021Room: V300 - Chad Littman Speaker
Kevin Saunders, PhD
Duke University
Immunogen Design for Broadly Neutralizing Antibody Induction
Short Talk: Structural Characterization of Affinity Maturation in the HIV-1 Glycan-V3 DH270 Broadly Neutralizing Antibody B Cell Lineage
10:40 AM - 10:55 AM EDT
Wednesday, June 2, 2021Room: V300 - Chad Littman Speaker
Rory Henderson, PhD
Duke University
Immunogen Design for Broadly Neutralizing Antibody Induction
Short Talk: Exploiting the HIV Glycan Shield Network Topology Towards Immunogen Design
10:55 AM - 11:10 AM EDT
Wednesday, June 2, 2021Room: V300 - Chad Littman Speaker
Srirupa Chakraborty, PhD
Los Alamos National Laboratory
Immunogen Design for Broadly Neutralizing Antibody Induction
Short Talk: Elicitation of V2 Apex Targeting Neutralizing Antibodies by SIVcpz Envs
11:10 AM - 11:25 AM EDT
Wednesday, June 2, 2021Room: V300 - Chad Littman Speaker
Ronnie Russell, BS
University of Pennsylvania
Immunogen Design for Broadly Neutralizing Antibody Induction
Inducing/Modulating Antibody Effector Functions
11:45 AM - 2:00 PM EDT
Wednesday, June 2, 2021Room: V200 - Ian Loudon Co-Chairs
Georgia Tomaras, PhD
Duke Human Vaccine Institute,
Jay Berzofsky, MD, PhD
NCI, National Institutes of Health
Inducing/Modulating Antibody Effector Functions
Broadly HIV-1 Neutralizing IgA Antibodies
11:45 AM - 12:10 PM EDT
Wednesday, June 2, 2021Room: V200 - Ian Loudon Speaker
Hugo Mouquet, PhD
Institut Pasteur
Inducing/Modulating Antibody Effector Functions
Optimizing Antibodies for Antiviral Activity in vivo
12:10 PM - 12:35 PM EDT
Wednesday, June 2, 2021Room: V200 - Ian Loudon Speaker
Margaret Ackerman, PhD
Dartmouth College
Inducing/Modulating Antibody Effector Functions
Single Cell Technologies Indicate Monocyte Expression Profiles Influence HIV Reservoir Size and Vaccine Efficacy
12:35 PM - 1:00 PM EDT
Wednesday, June 2, 2021Room: V200 - Ian Loudon Speaker
Rasmi Thomas, PhD
U.S. Military HIV Research Program
Inducing/Modulating Antibody Effector Functions
Short Talk: Broadly Neutralizing Antibody Recognition of HIV Envelope Epitopes Modulates Effector Function
1:00 PM - 1:15 PM EDT
Wednesday, June 2, 2021Room: V200 - Ian Loudon Speaker
Meredith Phelps, BS
Harvard University
Inducing/Modulating Antibody Effector Functions
Short Talk: The High-affinity Immunoglobulin Receptor FcgRI Potentiates HIV-1 Neutralization via Antibodies against the gp41 N-heptad Repeat: Implications for Vaccine Development
1:15 PM - 1:30 PM EDT
Wednesday, June 2, 2021Room: V200 - Ian Loudon Speaker
Maria Filsinger Interrante, BS
Stanford University
Inducing/Modulating Antibody Effector Functions
Short Talk: IgG Fc Sialylation is Regulated during the Germinal Center Reaction Following Immunization with Different Adjuvants
1:30 PM - 1:45 PM EDT
Wednesday, June 2, 2021Room: V200 - Ian Loudon Speaker
Marc Ehlers, PhD
University of Luebeck
Inducing/Modulating Antibody Effector Functions
Short Talk: Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of HIV-1 Envelope to Elicit Cross-Clade Response with Potent Fc-effector Functions
1:45 PM - 2:00 PM EDT
Wednesday, June 2, 2021Room: V200 - Ian Loudon Speaker
Rebekah Sherburn, PhD
Uniformed Services University of the Health Sciences
Inducing/Modulating Antibody Effector Functions
[Joint Session] Meet the Editors Roundtable
4:30 PM - 5:30 PM EDT
Wednesday, June 2, 2021Speakers
Montserrat Cols-Vidal, PhD
Journal of Experimental Medicine
Zeljko Durdevic, PhD
EMBO Press
Sarah Hamilton, PhD
Cell Reports Medicine
Alison Farrell, PhD
Nature Medicine
Keystone Symposia Roundtables
Thursday, June 3, 2021
Optimizing Germinal Center Responses for Broadly Neutralizing Antibody Induction
9:00 AM - 11:25 AM EDT
Thursday, June 3, 2021Room: V300 - Chad Littman Co-Chairs
Rogier Sanders, PhD
University of Amsterdam and Weill Cornell Medical College
Kevin Saunders, PhD
Duke University
Optimizing Germinal Center Responses for Broadly Neutralizing Antibody Induction
GC Regulation Learning from Mice and Men
9:00 AM - 9:25 AM EDT
Thursday, June 3, 2021Room: V300 - Chad Littman Speaker
Michel Nussenzweig, MD, PhD
HHMI/Rockefeller University
Optimizing Germinal Center Responses for Broadly Neutralizing Antibody Induction
Exploiting the Immunological Environment Supporting HIV-1 BnAb Induction During Infection to Inform Vaccine Design
9:25 AM - 9:50 AM EDT
Thursday, June 3, 2021Room: V300 - Chad Littman Speaker
Persephone Borrow, PhD
University of Oxford
Optimizing Germinal Center Responses for Broadly Neutralizing Antibody Induction
Designing Immunization Regimens to Promote the Germinal Center Response
9:50 AM - 10:15 AM EDT
Thursday, June 3, 2021Room: V300 - Chad Littman Speaker
Darrell Irvine, PhD
Massachusetts Institute of Technology
Optimizing Germinal Center Responses for Broadly Neutralizing Antibody Induction
Targeting HIV-1 ENV V2-apex bNAb Precursors in Human Ig Knock-in Mouse Models
10:15 AM - 10:40 AM EDT
Thursday, June 3, 2021Room: V300 - Chad Littman Speaker
Facundo Batista, PhD
Massachusetts Institute of Technology and Harvard University
Optimizing Germinal Center Responses for Broadly Neutralizing Antibody Induction
Short Talk: HLA-II Associated Viral Adaptation Impacts the Quantity and Quality of CD4+ T-Cell Responses in HIV-1 Vaccine Recipients
10:40 AM - 10:55 AM EDT
Thursday, June 3, 2021Room: V300 - Chad Littman Speaker
Jacob Files, BS
University of Alabama Birmingham
Optimizing Germinal Center Responses for Broadly Neutralizing Antibody Induction
Short Talk: Sequential Immunization Strategies To Elicit Anti HIV-1 Broadly Neutralizing Antibodies
10:55 AM - 11:10 AM EDT
Thursday, June 3, 2021Room: V300 - Chad Littman Speaker
Amelia Escolano, PhD
Rockefeller University
Optimizing Germinal Center Responses for Broadly Neutralizing Antibody Induction
Short Talk: Fusion Peptide Priming and Long Trimer Interval Reduces Off-target Antibody Responses Toward the HIV-1 Trimer Base Region
11:10 AM - 11:25 AM EDT
Thursday, June 3, 2021Room: V300 - Chad Littman Speaker
Angela Corrigan, BS
NIAID, National Institutes of Health
Optimizing Germinal Center Responses for Broadly Neutralizing Antibody Induction
CD8 T Cell Inducing Vaccines
11:45 AM - 1:25 PM EDT
Thursday, June 3, 2021Room: V200 - Ian Loudon Co-Chairs
Persephone Borrow, PhD
University of Oxford
Bruce Walker, MD
Ragon Institute of MGH, MIT and Harvard
CD8 T Cell Inducing Vaccines
Latest Developments in CMV-Vectored HIV/SIV Vaccines
11:45 AM - 12:10 PM EDT
Thursday, June 3, 2021Room: V200 - Ian Loudon Speaker
Louis Picker, MD
Oregon Health & Science University
CD8 T Cell Inducing Vaccines
Understanding HLA-E Mediated Antigen Presentation to Inform Vaccine Design
12:10 PM - 12:35 PM EDT
Thursday, June 3, 2021Room: V200 - Ian Loudon Speaker
Andrew McMichael, MD, PhD
Oxford University
CD8 T Cell Inducing Vaccines
Design of Vaccines to Elicit Conventional (la)-restricted CD8 T Cell Responses
12:35 PM - 1:00 PM EDT
Thursday, June 3, 2021Room: V200 - Ian Loudon Speaker
Bette Korber, PhD
Los Alamos National Laboratory
CD8 T Cell Inducing Vaccines
CD8+ T Cell Tissue Recirculation and Residency in HIV Infection
1:00 PM - 1:25 PM EDT
Thursday, June 3, 2021Room: V200 - Ian Loudon Speaker
Michael Betts, PhD
University of Pennsylvania
CD8 T Cell Inducing Vaccines
Friday, June 4, 2021
[Joint Session] Therapeutic Vaccines
9:00 AM - 11:50 AM EDT
Friday, June 4, 2021Room: V100 - Ben Schramm Co-Chairs
Bonnie Howell, PhD
Merck & Co., Inc.
Michael Betts, PhD
University of Pennsylvania
[Joint Session] Therapeutic Vaccines
Therapeutic Vaccines – Preclinical to Clinical Trials
9:00 AM - 9:25 AM EDT
Friday, June 4, 2021Room: V100 - Ben Schramm Speaker
Barbara Felber, PhD
NCI, National Institutes of Health
[Joint Session] Therapeutic Vaccines
Therapeutic Antibody and Vaccine Strategies
9:25 AM - 9:50 AM EDT
Friday, June 4, 2021Room: V100 - Ben Schramm Speaker
Dan Barouch, MD, PhD
Beth Israel Deaconess Medical Center
[Joint Session] Therapeutic Vaccines
HIV Remission in Acutely Treated Populations
9:50 AM - 10:15 AM EDT
Friday, June 4, 2021Room: V100 - Ben Schramm Speaker
Julie Ake, MD
Walter Reed Army Institute of Research
[Joint Session] Therapeutic Vaccines
Target-Intrinsic CTL Resistance, A Role in Reservoir Persistence?
10:15 AM - 10:40 AM EDT
Friday, June 4, 2021Room: V100 - Ben Schramm Speaker
Brad Jones, PhD
Weill Cornell Medicine
[Joint Session] Therapeutic Vaccines
AELIX-002: A RCT with HTI Therapeutic Vaccines in Early-Treated HIV
10:40 AM - 11:05 AM EDT
Friday, June 4, 2021Room: V100 - Ben Schramm Speaker
Beatriz Mothe, MD, PhD
IrsiCaixa AIDS Research Institute-HIVACAT
[Joint Session] Therapeutic Vaccines
Short Talk: Duodenal Tissue-Resident CD8+ T Cells Exhibit Low Cytolytic Molecule Expression and Spatially Localise Away from HIV-Susceptible CD4+ T Cells
11:05 AM - 11:20 AM EDT
Friday, June 4, 2021Room: V100 - Ben Schramm Speaker
Leonard Mvaya
Malawi-Liverpool Wellcome Trust Clinical Research Programme
[Joint Session] Therapeutic Vaccines
Short Talk: Non-Cytotoxic Signatures Dominate HIV Specific T Cell Responses in Viremic Non-Progression
11:20 AM - 11:35 AM EDT
Friday, June 4, 2021Room: V100 - Ben Schramm Speaker
Amit Kumar Singh, MS
National Institute for Research in Reproductive Health
[Joint Session] Therapeutic Vaccines
Short Talk: The Contribution of CD8+ T Lymphocytes to HIV/SIV Persistence during ART
11:35 AM - 11:50 AM EDT
Friday, June 4, 2021Room: V100 - Ben Schramm Speaker
Deanna Kulpa, PhD
Emory University
[Joint Session] Therapeutic Vaccines
